Assessment of systemic immune-inflammation index as an independent surrogate biomarker of no-reflow phenomenon in acute coronary syndrome patients with …
OBJECTIVE: Numerous mechanisms have been proposed for the no-reflow phenomenon
(NRP) in the literature including leukocyte intravascular plugging, microembolisms, and …
(NRP) in the literature including leukocyte intravascular plugging, microembolisms, and …
No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score
LP Dawson, M Rashid, DT Dinh… - Circulation …, 2024 - Am Heart Assoc
BACKGROUND: Suboptimal coronary reperfusion (no reflow) is common in acute coronary
syndrome percutaneous coronary intervention (PCI) and is associated with poor outcomes …
syndrome percutaneous coronary intervention (PCI) and is associated with poor outcomes …
A Predictor of Contrast-Induced Nephropathy After Carotid Angiography
Dear Editor, We read with great interest the article entitled “C-Reactive Protein to Albumin
Ratio as a Predictor of Contrast-Induced Nephropathy After Carotid Angiography” by …
Ratio as a Predictor of Contrast-Induced Nephropathy After Carotid Angiography” by …
Impact of HAT2CH2 Score on the Development of No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction
H Harbalıoğlu, Ö Genç, G Alıcı, A Quisi… - Angiology, 2024 - journals.sagepub.com
The HAT2CH2 score [Hypertension (1 point), Age> 75 years (1 point), Stroke/Transient
ischemic attack (2 points), Chronic obstructive pulmonary disease (1 point), and Heart failure …
ischemic attack (2 points), Chronic obstructive pulmonary disease (1 point), and Heart failure …
Relationship between high sensitivity C-reactive protein to albumin ratio with infarct-related artery patency in patients with non-ST-segment elevation myocardial …
C Özkan, O Karayiğit - Angiology, 2023 - journals.sagepub.com
The C-reactive protein/albumin ratio (CAR) has recently emerged as a marker for poor
prognosis or mortality in various patient groups. This study aimed to examine the …
prognosis or mortality in various patient groups. This study aimed to examine the …
Artificial Intelligence Evaluation of the Utility of HALP Score and Hematological Indicators in Estimating No-Reflow After Primary Percutaneous Coronary Intervention …
R Yilmaz - International Journal of Current Medical and Biological …, 2023 - ijcmbs.com
Background: Acute Myocardial Infarction (AMI) is a leading cause of mortality globally, with
ST-segment Elevation Myocardial Infarction (STEMI) being a specific type. The study aims to …
ST-segment Elevation Myocardial Infarction (STEMI) being a specific type. The study aims to …
A Novel Marker Triglyceride Glucose Index in Predicting the Development of No-reflow in Acute Coronary Syndrome without ST-segment Elevation.
M Altunova, M Koseoglu - Medical Bulletin of Haseki/Haseki …, 2024 - search.ebscohost.com
Abstract Aim: The triglyceride-glucose (TyG) index is a new marker that predicts adverse
clinical outcomes in coronary artery disease. We aimed to investigate the relationship …
clinical outcomes in coronary artery disease. We aimed to investigate the relationship …
A new inflammatory marker of the no-reflow phenomenon after Percutaneous Coronary Intervention (PCI) to saphenous venous in patients with coronary artery …
Background: Although numerous mechanisms regarding the no-reflow phenomenon (NRP)
have been mentioned, they have not yet been fully elucidated. The NRP can impact the …
have been mentioned, they have not yet been fully elucidated. The NRP can impact the …